查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916879

一次性输液袋市场按材质、产品类型、容量、最终用户和应用划分－全球预测（2026-2032 年）

Disposable Infusion Bag Market by Material, Product Type, Capacity, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，一次性输液袋市场价值将达到 33.4 亿美元，到 2026 年将成长至 35.8 亿美元，到 2032 年将达到 56.7 亿美元，年复合成长率为 7.84%。

主要市场统计数据
基准年 2025 33.4亿美元
预计年份：2026年 35.8亿美元
预测年份：2032年 56.7亿美元
复合年增长率 (%) 7.84%

对一次性输液袋进行了清晰的介绍，重点阐述了其在医疗保健服务中的临床必要性、材料选择、设备配置和操作重要性。

一次性输液袋已成为现代静脉输液治疗中不可或缺的器械，它们兼具一次性使用的安全性，并采用日益精密的工艺设计，以满足临床、物流和监管方面的需求。近年来，感染控制、降低交叉感染风险以及可追溯供应链等临床重点，与聚合物科学和製造技术的进步相结合，使得无菌即用型输液系统成为可能。因此，临床医生和采购经理优先考虑那些能够最大限度减少操作、简化给药流程并支援多种治疗应用（从输血和肠外营养到化疗和疫苗接种）的器械。

全面概述重塑一次性输液袋创新、材料应用、临床工作流程和永续性趋势的主要结构性变化

一次性输液袋市场格局正经历变革时期，这场变革受到技术、监管和医疗服务模式变化的驱动，并正在重塑产品设计和采购行为。在材料方面，人们已显着地从传统的塑化剂转向其他聚合物体系，这些体系既能减少患者接触有害添加剂的机会，又能保持所需的机械性能。聚烯和乙烯-醋酸乙烯酯树脂配方的广泛应用也促进了这一转变，这些配方具有优异的耐化学性和灭菌兼容性。同时，产品结构也在不断发展。多腔室结构可实现按需分隔和更安全的混合流程，而预填充的单腔室设计则可加快床边给药速度并减少配药错误。

分析2025年美国关税对采购、生产策略、供应商谈判和临床供应连续性的连锁反应

2025年关税政策的实施为一次性输液袋生态系统带来了新的商业和营运挑战，促使製造商、经销商和医疗系统重新评估其采购和成本管理策略。依赖进口的零件和成品到岸成本上升，迫使采购团队探索替代供应商、近岸外包方案以及长期供应商协议，以确保供应的连续性和价格的可预测性。这些发展加速了垂直整合和扩大区域生产能力的讨论，以降低贸易政策波动带来的风险。

透过精细的細項分析进行策略规划，将最终用户、材料系列、产品架构、销售范围和治疗应用连结起来。

详细的细分框架揭示了临床应用案例、材料科学、产品设计、容量选择和治疗应用如何相互交织，从而指导采购和开发决策。在评估最终使用者时，临床环境包括：便携性和易用性至关重要的门诊中心；设有普通病房、加护病房和门诊药房的医院（每个场所的处理和管理需求各不相同）；以及需要针对特定疗法进行特殊配置的专科诊所。材料细分重点介绍了乙烯-醋酸乙烯酯树脂（兼具柔软性和透明性）、聚烯（包括共聚物和均聚物，在韧性和加工性能方面各有侧重）以及聚氯乙烯（PVC）等材料，其中传统应用与新兴的无邻苯二甲酸乙二醇酯（DEHP）替代品并存，因为买家会考虑生物相容性和监管偏好。

区域分析揭示了地理法规结构、生产能力和医疗服务模式对一次性输液袋普及应用的影响。

区域趋势对美洲、欧洲、中东和非洲以及亚太等关键区域的产品偏好、监管要求和供应链策略有显着影响。在美洲，采购重点通常在于可扩展性、支援家庭和门诊输液服务以及符合区域安全和标籤标准，这就要求供应商提供高效的分销网络和本地化的技术支援。在欧洲、中东和非洲，法规环境各不相同，包括对某些塑化剂的限制以及该地区部分地区日益严格的环境法规，这迫使买家选择不含邻苯二甲酸二辛酯（DEHP）的产品和更可持续的材料。同时，跨多个市场进口的复杂性也提升了区域製造伙伴关係的价值。

深入洞察关键公司趋势和竞争考察，强调技术差异化、供应链敏捷性和监管准备对于塑造输液袋领域领导地位的重要性。

一次性输液袋市场的竞争格局主要由那些兼具聚合物科学能力、严格的品管系统和灵活製造地的公司所主导。领先的供应商透过提供客製化的产品设计来脱颖而出，这些设计包括多腔结构和预填充单腔装置，以适应不同的临床工作流程，此外，他们还提供检验的灭菌工艺和多种材料选择。契约製造在新参与企业和利基产品开发人员中扮演着至关重要的角色，他们提供规模化生产方面的专业知识、法规文件支援和柔软性的生产方式，从而加速创新设计在临床上的应用。

为製造商和医疗保健采购团队提供切实可行的策略建议，以有效管理物料过渡、采购风险和产品差异化。

产业领导者应采取积极主动的策略，使产品开发、供应链韧性和商业性合作与不断变化的临床和监管要求保持一致。首先，应优先考虑传统塑化剂的替代品，并製定材料蓝图，其中包括聚烯和乙烯-醋酸乙烯酯共聚物 (EVA) 等材料，并评估其与治疗液和灭菌方法的兼容性，同时进行严格的萃取物和浸出物测试以及临床检验。其次，透过生产和采购多元化，将区域生产能力与策略供应商关係结合，可以降低受贸易政策变化的影响，并提高重症监护环境下的前置作业时间可靠性。

该研究采用透明的调查方法，将对临床医生和采购负责人的初步调查与对材料、法规和供应链趋势的二次检验相结合。

本报告的调查方法结合了初步定性研究和严谨的二次检验，旨在提供以临床医生为中心的、可操作的洞见。初步研究包括对加护病房、门诊药房、门诊输液服务中心和专科诊所的临床医生进行结构化访谈和研讨会。此外，还与采购和生产部门的高阶主管进行了沟通，以了解营运重点和供应链限制。这些访谈辅以实地考察和观察性研究，以评估医疗设备在实际环境中的操作、标籤和与输液系统的兼容性。

摘要重点阐述了临床安全、材料创新、监管压力和供应链韧性如何相互作用，共同塑造这一领域。

一次性输液袋领域处于临床安全、材料创新和供应链策略的交汇点，这不仅为製造商带来了机会，也带来了挑战。聚合物科学的进步、产品结构的演进以及医疗服务模式的转变，都推动了能够降低操作风险、提高病患安全并拓展治疗应用范围的医疗器材的研发。同时，日益严格的监管审查和关税等政策措施，也凸显了供应链韧性、材料透明度和在地化生产能力的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 一次性输液袋市场（依材料分类）

  • 乙烯-醋酸乙烯酯共聚物
  • 聚烯
    • 共聚物
    • 均聚物
  • PVC
    • 含有邻苯二甲酸二辛酯（DEHP）。
    • 不含DEHP

9. 一次性输液袋市场（依产品类型划分）

  • 多重腔体
    • 四室型
    • 三室型
    • 双腔型
  • 单室
    • 非预填充
    • 预填充

第十章 一次性输液袋市场（以销售量计）

  • 500～1,000ml
    • 500～750ml
    • 750～1,000ml
  • 500毫升或以下
    • 0～250ml
    • 250～500ml
  • 超过1000毫升
    • 1,000～1,500ml
    • 超过1500毫升

第十一章：以最终用户分類的一次性输液袋市场

  • 门诊治疗中心
  • 医院
    • 普通病房
    • 加护病房
    • 门诊药房
  • 专科诊所

第十二章：一次性输液袋市场（按应用领域划分）

  • 输血
    • 电浆
    • 血小板
    • 红血球
  • 药物输送
    • 止痛药
    • 抗生素
    • 化疗
    • 疫苗
  • 肠外营养
    • 周边静脉营养
    • 全静脉营养

第十三章：按地区分類的一次性输液袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 一次性输液袋市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国一次性输液袋市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国一次性输液袋市场

第十七章：中国一次性输液袋市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alfa Laboratories
  • APG Europe
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biometrix Corporation
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Fairmont Medica
  • Fresenius Kabi AG
  • Hospira by Pfizer Inc.
  • ICU Medical, Inc.
  • Kraton Corporation
  • LyondellBasell Industries Holdings BV
  • Medicopack A/S
  • Mitra Industries Private Limited
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Poly Medicure Limited
  • Polycine GmbH
  • Qosina Corporation
  • RAUMEDIC AG
  • Shandong Weigao Group Medical Polymer Co., Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB153CA

The Disposable Infusion Bag Market was valued at USD 3.34 billion in 2025 and is projected to grow to USD 3.58 billion in 2026, with a CAGR of 7.84%, reaching USD 5.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.34 billion
Estimated Year [2026] USD 3.58 billion
Forecast Year [2032] USD 5.67 billion
CAGR (%) 7.84%

Clear introduction to disposable infusion bags emphasizing clinical imperatives, material choices, device configurations and operational importance for healthcare delivery

The disposable infusion bag has become an essential device within modern intravenous therapy, combining single-use safety with increasing design sophistication to meet clinical, logistical, and regulatory demands. Over recent years clinical priorities such as infection control, reduction of cross-contamination risk, and the need for traceable supply chains have converged with advances in polymer science and manufacturing that enable sterile, ready-to-use fluid delivery systems. As a result, clinicians and procurement leaders are prioritizing devices that minimize handling, simplify administration, and support a variety of therapeutic applications from blood transfusion and parenteral nutrition to chemotherapy and vaccination programs.

Operationally, disposable infusion bags reduce the complexity of reprocessing and lower the risk associated with reusable containers, which is particularly salient in high-acuity settings such as intensive care units. Concurrently, manufacturers are responding with a spectrum of product configurations, from single-chamber prefilled systems optimized for immediate clinical use to multi-chamber assemblies that enable complex compounding at the point of care. Material selection and biocompatibility considerations also underpin product choice, with decisions balancing flexibility, clarity, chemical resistance, and potential leachables. Taken together, these dynamics position the disposable infusion bag as a focal point for clinical efficiency, patient safety, and supply chain resilience across care settings.

Comprehensive overview of the major structural shifts reshaping disposable infusion bag innovations, materials adoption, clinical workflows and sustainability trends

The disposable infusion bag landscape is undergoing transformative shifts driven by technological, regulatory, and care-delivery changes that are reshaping product design and procurement behaviors. On the materials front, there is a notable migration away from legacy plasticizers toward alternative polymer systems that reduce potential patient exposure to problematic additives while preserving necessary mechanical properties. This transition is complemented by the broader adoption of polyolefin and ethylene-vinyl acetate formulations that offer favorable chemical resistance and sterilization compatibility. Simultaneously, product architecture is evolving: multi-chamber constructs enable on-demand compartmentalization and safer admixture workflows, while prefilled single-chamber options accelerate bedside administration and reduce compounding errors.

Care delivery models are also changing, with greater emphasis on ambulatory and home infusion services that demand compact, user-friendly packaging and simplified administration protocols. Digital enablers such as serialized labeling, RFID tags, and connectivity for inventory management are beginning to integrate with device supply chains to support traceability and reduce waste. Lastly, heightened attention to environmental sustainability is prompting manufacturers and health systems to reassess material sourcing, sterilization footprints, and end-of-life handling, catalyzing investment in recyclable or more readily incinerable materials and in supply chain measures that reduce unnecessary packaging and transport emissions.

Analysis of the ripple effects of 2025 United States tariff measures on sourcing, production strategies, supplier negotiations and clinical supply continuity

Tariff actions implemented in 2025 have introduced a new layer of commercial and operational considerations across the disposable infusion bag ecosystem, prompting manufacturers, distributors, and health systems to reassess sourcing and cost-management strategies. Import-dependent components and finished goods experienced increased landed costs, which in turn pressured procurement teams to explore alternative suppliers, nearshoring options, and longer-term supplier agreements to secure supply continuity and predictable pricing. These dynamics accelerated conversations about vertical integration and the expansion of regional manufacturing capacity to mitigate exposure to trade policy volatility.

Beyond procurement, tariffs influenced material substitution decisions where feasible, encouraging the adoption of locally sourced polymers or alternative formulations that meet clinical and regulatory requirements while reducing tariff exposure. For many manufacturers, tariff-driven cost increases translated into tighter margin management and targeted efficiency programs across production and distribution. Health systems responded by reevaluating contractual terms, extending purchasing timelines, and seeking collaborative cost-sharing arrangements with suppliers. In parallel, regulatory compliance burdens related to material changes required careful validation, documentation, and clinician engagement to ensure clinical performance and safety were sustained during transitions away from tariff-affected sources.

Nuanced segmentation insight connecting end users, material families, product architectures, capacity ranges and therapeutic applications to inform strategy

A detailed segmentation framework reveals how clinical use cases, material science, product design, capacity choices, and therapeutic applications intersect to guide procurement and development decisions. When evaluating end users, clinical settings include ambulatory care centers where portability and ease of use are paramount, hospitals which encompass general wards, intensive care units, and outpatient pharmacies each with distinct handling and administration needs, and specialty clinics that often require tailored configurations for niche therapies. Material segmentation highlights ethylene-vinyl acetate as an option for flexibility and clarity, polyolefin families including copolymer and homopolymer variants that offer differing balances of toughness and processability, and PVC choices where legacy use and newer DEHP-free alternatives coexist as buyers weigh biocompatibility and regulatory preferences.

Product-type differentiation spans multi-chamber systems available in four-, three-, and two-chamber architectures that support complex compounding and staged delivery, alongside single-chamber solutions offered as either non-prefilled containers for on-site preparation or prefilled units for rapid administration. Capacity considerations include ranges below 500 milliliters with subbands for very low volume parenteral use, mid-range volumes between 500 and 1000 milliliters with further distinction for commonly used clinical bandings, and larger formats exceeding 1000 milliliters for high-volume infusion or specialized therapies. Application-focused segmentation captures blood transfusion needs across plasma, platelets, and red blood cells; drug delivery categories encompassing analgesics, antibiotics, chemotherapy agents, and vaccines; and parenteral nutrition requirements divided into peripheral and total parenteral nutrition, each with specific formulation and container compatibility implications. Integrating these dimensions enables more granular supplier selection, regulatory planning, and product roadmaps that align with the distinct functional needs of clinical specialties and care settings.

Regional analysis spotlighting how geographic regulatory frameworks, manufacturing capabilities and care delivery models shape disposable infusion bag adoption

Regional dynamics materially influence product preferences, regulatory expectations, and supply chain strategies across the principal geographies of the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, procurement emphasis often centers on scalability, support for home and ambulatory infusion services, and compliance with regional safety and labeling standards, encouraging suppliers to offer streamlined distribution and localized technical support. Europe, Middle East & Africa presents a heterogeneous regulatory environment where restrictions on certain plasticizers and heightened environmental mandates in parts of the region push buyers toward DEHP-free options and more sustainable material choices, while import complexity in several markets increases the value of regional manufacturing partnerships.

Asia-Pacific is characterized by a robust manufacturing base combined with growing clinical demand, which creates opportunities for suppliers to scale production and introduce cost-effective innovations. However, diverse regulatory regimes and varying levels of clinical infrastructure create a differentiated adoption curve for advanced device formats. Across all regions, supply chain resilience, regulatory harmonization efforts, and growing emphasis on lifecycle environmental performance are shaping procurement criteria and supplier selection, with buyers increasingly seeking partners who can offer compliant, reliable, and locally supported solutions.

Key corporate and competitive insights revealing how technological differentiation, supply chain agility and regulatory readiness shape leadership in the infusion bag sector

Competitive dynamics in the disposable infusion bag space favor organizations that combine technical competence in polymer science with rigorous quality systems and adaptive manufacturing footprints. Leading suppliers differentiate by offering a suite of material options, validated sterilization processes, and customizable product architectures such as multi-chamber configurations and prefilled single-chamber units that address diverse clinical workflows. Contract manufacturing organizations play a pivotal role for new entrants and niche product developers, providing scale-up expertise, regulatory documentation support, and manufacturing flexibility that accelerates time-to-clinic for innovative designs.

Strategic initiatives observed among incumbents include targeted investments in material substitution to address biocompatibility and sustainability goals, expansion of regional production capacity to mitigate trade exposure, and development of digital documentation and traceability tools to meet stricter regulatory and hospital compliance requirements. Partnerships across the supply chain-linking polymer suppliers, component manufacturers, and clinical services providers-are increasingly important to ensure end-to-end validation and continuity. Firms that can demonstrate consistent quality, clear regulatory pathways, and the ability to support clinical customers with training and field service tend to secure longer-term procurement relationships and preferred supplier status in healthcare systems.

Actionable strategic recommendations for manufacturers and healthcare procurement teams to manage materials transitions, sourcing risk and product differentiation effectively

Industry leaders should adopt a proactive strategy that aligns product development, supply chain resilience, and commercial engagement with evolving clinical and regulatory expectations. First, develop a materials roadmap that prioritizes alternatives to legacy plasticizers and assesses polyolefin and ethylene-vinyl acetate options for compatibility with therapeutic fluids and sterilization methods, accompanied by robust extractables and leachables testing and clinical validation. Second, diversify manufacturing and sourcing by combining regional production capacity with strategic supplier relationships to reduce exposure to trade policy shifts and to improve lead-time reliability for critical care settings.

Third, invest in product portfolio differentiation by expanding multi-chamber solutions for complex admixture workflows while scaling prefilled single-chamber options for ambulatory and vaccination programs, ensuring that packaging and labeling designs support rapid adoption and safe handling. Fourth, implement pricing and contracting frameworks that share tariff and supply volatility risks through longer-term agreements, indexation clauses, and collaborative inventory planning with major health system customers. Fifth, embed sustainability metrics into procurement and product development decisions, focusing on material selection, waste reduction, and end-of-life pathways that align with institutional environmental goals. Finally, strengthen clinical engagement and training programs to ensure safe transition to new materials or product architectures, thereby building clinician confidence and accelerating adoption.

Transparent research methodology blending primary clinician and procurement engagement with secondary validation of materials, regulations and supply chain dynamics

The research methodology underpinning this report integrates primary qualitative inquiry with rigorous secondary validation to produce actionable, clinician-centered insights. Primary research included structured interviews and workshops with clinicians across intensive care, outpatient pharmacy, ambulatory infusion services, and specialty clinics, as well as conversations with procurement leaders and manufacturing executives to capture operational priorities and supply chain constraints. These interviews were complemented by site visits and observational studies where device handling, labeling, and compatibility with infusion systems were assessed in real-world settings.

Secondary research drew on peer-reviewed literature, regulatory agency guidance, standards documentation, patent landscapes, and clinical guideline repositories to validate material safety profiles, sterilization approaches, and recommended handling practices. Supply chain mapping and materials analysis provided visibility into component sourcing and potential bottlenecks, while scenario analysis explored the implications of trade policy changes, regulatory shifts, and adoption patterns. Findings were triangulated through expert panels and iterative validation with industry stakeholders to ensure the conclusions are robust, clinically relevant, and operationally actionable.

Concluding synthesis highlighting the interplay of clinical safety, materials innovation, regulatory pressures and supply chain resilience shaping the sector

The disposable infusion bag sector sits at the intersection of clinical safety, materials innovation, and supply chain strategy, creating both opportunities and obligations for manufacturers and healthcare providers. Advances in polymer science, evolving product architectures, and shifting care delivery models support the development of devices that reduce handling risk, improve patient safety, and enable a wider range of therapeutic applications. At the same time, regulatory scrutiny and policy measures such as tariffs have amplified the importance of supply chain resilience, material transparency, and regional manufacturing capacity.

Decision-makers must therefore balance clinical performance with operational continuity and environmental responsibility, adopting materials roadmaps, diversification strategies, and clinician-engagement programs that de-risk transitions and support sustained adoption. By aligning product design with end-user workflows and regional regulatory expectations, stakeholders can deliver safer, more reliable infusion solutions that meet the needs of acute care, ambulatory settings, and expanding home-infusion models. Continued collaboration across manufacturers, clinicians, regulators, and procurement teams will be essential to realize these benefits while managing costs and compliance obligations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Infusion Bag Market, by Material

  • 8.1. Ethylene-Vinyl Acetate
  • 8.2. Polyolefin
    • 8.2.1. Copolymer
    • 8.2.2. Homopolymer
  • 8.3. Pvc
    • 8.3.1. Dehp Containing
    • 8.3.2. Dehp Free

9. Disposable Infusion Bag Market, by Product Type

  • 9.1. Multi-Chamber
    • 9.1.1. Four Chamber
    • 9.1.2. Three Chamber
    • 9.1.3. Two Chamber
  • 9.2. Single Chamber
    • 9.2.1. Non-Prefilled
    • 9.2.2. Prefilled

10. Disposable Infusion Bag Market, by Capacity

  • 10.1. 500-1000 Ml
    • 10.1.1. 500-750 Ml
    • 10.1.2. 750-1000 Ml
  • 10.2. <500 Ml
    • 10.2.1. 0-250 Ml
    • 10.2.2. 250-500 Ml
  • 10.3. >1000 Ml
    • 10.3.1. 1000-1500 Ml
    • 10.3.2. >1500 Ml

11. Disposable Infusion Bag Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Hospitals
    • 11.2.1. General Ward
    • 11.2.2. Icu
    • 11.2.3. Outpatient Pharmacy
  • 11.3. Specialty Clinics

12. Disposable Infusion Bag Market, by Application

  • 12.1. Blood Transfusion
    • 12.1.1. Plasma
    • 12.1.2. Platelets
    • 12.1.3. Red Blood Cells
  • 12.2. Drug Delivery
    • 12.2.1. Analgesics
    • 12.2.2. Antibiotics
    • 12.2.3. Chemotherapy
    • 12.2.4. Vaccines
  • 12.3. Parenteral Nutrition
    • 12.3.1. Peripheral Parenteral Nutrition
    • 12.3.2. Total Parenteral Nutrition

13. Disposable Infusion Bag Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Disposable Infusion Bag Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Disposable Infusion Bag Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Disposable Infusion Bag Market

17. China Disposable Infusion Bag Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alfa Laboratories
  • 18.6. APG Europe
  • 18.7. B. Braun SE
  • 18.8. Baxter International Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. Biometrix Corporation
  • 18.11. CellBios Healthcare & Lifesciences Pvt. Ltd.
  • 18.12. Fairmont Medica
  • 18.13. Fresenius Kabi AG
  • 18.14. Hospira by Pfizer Inc.
  • 18.15. ICU Medical, Inc.
  • 18.16. Kraton Corporation
  • 18.17. LyondellBasell Industries Holdings B.V.
  • 18.18. Medicopack A/S
  • 18.19. Mitra Industries Private Limited
  • 18.20. Nipro Corporation
  • 18.21. Otsuka Pharmaceutical Co., Ltd.
  • 18.22. Poly Medicure Limited
  • 18.23. Polycine GmbH
  • 18.24. Qosina Corporation
  • 18.25. RAUMEDIC AG
  • 18.26. Shandong Weigao Group Medical Polymer Co., Ltd.
  • 18.27. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE INFUSION BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE INFUSION BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DISPOSABLE INFUSION BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DISPOSABLE INFUSION BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ETHYLENE-VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ETHYLENE-VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ETHYLENE-VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY COPOLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY COPOLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY COPOLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOMOPOLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOMOPOLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOMOPOLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DEHP CONTAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DEHP CONTAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DEHP CONTAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DEHP FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DEHP FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DEHP FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY FOUR CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY FOUR CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY FOUR CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY THREE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY THREE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY THREE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY TWO CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY TWO CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY TWO CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY NON-PREFILLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY NON-PREFILLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY NON-PREFILLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PREFILLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PREFILLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PREFILLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-750 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-750 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-750 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 750-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 750-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 750-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 0-250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 0-250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 0-250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 1000-1500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 1000-1500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY 1000-1500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY >1500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY GENERAL WARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY OUTPATIENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY OUTPATIENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL DISPOSABLE INFUSION BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 296. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 298. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 299. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 300. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 302. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 303. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 304. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 305. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 306. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY >1000 ML, 2018-2032 (USD MILLION)
  • TABLE 307. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 309. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 310. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2032 (USD MILLION)
  • TABLE 311. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 312. GCC DISPOSABLE INFUSION BAG MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY MULTI-CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY SINGLE CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY 500-1000 ML, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION DISPOSABLE INFUSION BAG MARKET SIZE, BY <500 ML, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION DISPOS